Clinical Trials Browser

Phase NA × EGFR Mutation Positive Non-small Cell Lung Cancer × Clear all

NCT01776684 2013-01-28

Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis

Phase NA Unknown

EGFR Mutation Positive Non-small Cell Lung Cancer